$71.80
-0.19-0.26%
Pre-Market: 4:11 AM EDT
15 minutes delayed
Moderna reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Moderna using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $-3.33 | $-3.39 | 1.77 % |
Mar 2024 | 2024-05-02 | $-3.07 | $-3.35 | 8.36 % |
Dec 2023 | 2024-02-22 | $0.55 | $-0.97 | 156.7 % |
Sep 2023 | 2023-11-02 | $-9.53 | $-1.93 | -393.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $241.00M | $132.18M | 82.3 % |
Mar 2024 | 2024-05-02 | $167.00M | $90.99M | 83.5 % |
Dec 2023 | 2024-02-22 | $2.81B | $2.49B | 12.9 % |
Sep 2023 | 2023-11-02 | $1.83B | $1.40B | 30.8 % |
Moderna (MRNA) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 1, 2024 for Q2.
The Actual EPS was $-3.33, which beat the estimate of $-3.39.
The Actual Revenue was $241M, which beat the estimate of $132.2M.
Browse earnings estimates, EPS, and revenue on all stocks.